KR920011490A - 척추 손상으로 인한 반사이상항진 치료용 3-아릴-5-알킬티오-4h-1, 2, 4-트리아졸 - Google Patents
척추 손상으로 인한 반사이상항진 치료용 3-아릴-5-알킬티오-4h-1, 2, 4-트리아졸 Download PDFInfo
- Publication number
- KR920011490A KR920011490A KR1019910023429A KR910023429A KR920011490A KR 920011490 A KR920011490 A KR 920011490A KR 1019910023429 A KR1019910023429 A KR 1019910023429A KR 910023429 A KR910023429 A KR 910023429A KR 920011490 A KR920011490 A KR 920011490A
- Authority
- KR
- South Korea
- Prior art keywords
- triazole
- phenyl
- methyl
- compound
- alkylthio
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (9)
- 하반기 일반식의 화합물 또는 약제학적으로 허용되는 염의 치료학적 유효량을 투여함을 포함하여, 척추 손상으로 인한 반사이상항진을 치료하는 방법.상기식에서, Ar은 페닐 또는 나프틸이고;R1은 C1-6저급 알킬이며;R2는 수소 또는 C1-6저급 알킬이고;R은 C1-6저급 알킬 C1-6알콕시, 하이드록시, 할로게노 또는 트리플루오로메틸이며;n은 0, 1 또는 2 이거나; 또는 Rn-(Ar)은 메틸렌디옥시페닐이며;m 및 q는 각각 0, 1 또는 2이다.
- 제1항에 있어서, Ar이 페닐인 방법.
- 제2항에 있어서, m이 0인 방법.
- 제1항에 있어서, n이 0 또는 1이고, m이 0이며, R이 할로겐이고, R1및 R2가 독립적으로 메틸 또는 에틸인 방법.
- 제4항에 있어서, q가 0인 방법.
- 제4항에 있어서, q가 1인 방법.
- 제4항에 있어서, q가 2인 방법.
- 제1항에 있어서, 상기 화합물이 4-메틸-3-페닐-5-메틸설포닐-4H-1, 2, 4-트리아졸, 4-메틸-3-페닐-5-에틸설포닐-4H-1, 2, 4-트리아졸, 5-에틸티오-3-(2-플루오로페닐)-4-메틸-4H-1, 2, 4-트리아졸, 3-(2-플루오로페닐)-4-메틸-5-메틸설포닐-4H-1, 2, 4-트리아졸 및 4-페틸-3-페닐-5-에틸설피닐-4H-1, 2, 4-트리아졸로 구성된 그룹중에서 선택되는 방법.
- 제1항에 있어서, 상기 화합물이 4-메틸-3-페닐-5-메틸설포닐-4H-1, 2, 4-트리아졸인 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63066690A | 1990-12-20 | 1990-12-20 | |
US07/630,666 | 1990-12-20 | ||
US7/630,666 | 1990-12-20 | ||
US07/769201 | 1991-10-04 | ||
US07/769,201 US5158968A (en) | 1987-01-27 | 1991-10-04 | 3-aryl-5-alkylthio-4H-1,2,4-traizoles for treatment of hyperreflexia due to spinal trauma |
US7/769,201 | 1991-10-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920011490A true KR920011490A (ko) | 1992-07-24 |
KR100192647B1 KR100192647B1 (ko) | 1999-06-15 |
Family
ID=27091200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910023429A KR100192647B1 (ko) | 1990-12-20 | 1991-12-19 | 3-아릴-5-알킬티오-4h-1,2,4,-트리아졸을 함유하는 척추 손상으로 인한 반사이상항진 치료용의 약제학적 조성물 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0495226B1 (ko) |
JP (1) | JP3048191B2 (ko) |
KR (1) | KR100192647B1 (ko) |
AT (1) | ATE128867T1 (ko) |
AU (1) | AU644500B2 (ko) |
DE (1) | DE69113773T2 (ko) |
DK (1) | DK0495226T3 (ko) |
IE (1) | IE68424B1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6960394A (en) * | 1993-05-28 | 1994-12-20 | Origin Medsystems, Inc. | Retracting tip trocar with plunger sensor |
DE4339412A1 (de) * | 1993-11-18 | 1995-05-24 | Bayer Ag | Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen |
JPH09315972A (ja) * | 1996-03-22 | 1997-12-09 | Chugai Pharmaceut Co Ltd | 脊髄損傷治療剤 |
AR022228A1 (es) * | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para la preparar dicha composicion |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2593084B2 (ja) * | 1986-12-19 | 1997-03-19 | メレルダウファーマスーティカルズ インコーポレーテッド | 5−アリールー3h−1,2,4−トリアゾールー3−オン類の神経変性障害の処置への用途 |
US4900743A (en) * | 1987-01-27 | 1990-02-13 | Merrell Dow Pharmaceuticals Inc. | 3-aryl-5-alkylthio-4H-1,2,4-triazoles |
-
1991
- 1991-12-16 AU AU89692/91A patent/AU644500B2/en not_active Ceased
- 1991-12-19 EP EP91121811A patent/EP0495226B1/en not_active Expired - Lifetime
- 1991-12-19 DE DE69113773T patent/DE69113773T2/de not_active Expired - Fee Related
- 1991-12-19 IE IE446091A patent/IE68424B1/en not_active IP Right Cessation
- 1991-12-19 DK DK91121811.3T patent/DK0495226T3/da active
- 1991-12-19 KR KR1019910023429A patent/KR100192647B1/ko not_active IP Right Cessation
- 1991-12-19 AT AT91121811T patent/ATE128867T1/de not_active IP Right Cessation
- 1991-12-20 JP JP3355001A patent/JP3048191B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69113773D1 (de) | 1995-11-16 |
DE69113773T2 (de) | 1996-04-25 |
EP0495226B1 (en) | 1995-10-11 |
EP0495226A2 (en) | 1992-07-22 |
AU644500B2 (en) | 1993-12-09 |
IE914460A1 (en) | 1992-07-01 |
JPH04334373A (ja) | 1992-11-20 |
JP3048191B2 (ja) | 2000-06-05 |
ATE128867T1 (de) | 1995-10-15 |
EP0495226A3 (en) | 1992-09-16 |
AU8969291A (en) | 1992-06-25 |
KR100192647B1 (ko) | 1999-06-15 |
IE68424B1 (en) | 1996-06-12 |
DK0495226T3 (da) | 1995-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2219167C2 (ru) | N-замещенные аминотетралины как лиганды для рецептора y5 нейропептида y, полезные при лечении ожирения и других расстройств | |
KR970706818A (ko) | 뉴로펩티드 y와 관련된 상태의 억제 방법(methods of inhibiting conditions associated with neuropeptide) | |
KR950010893A (ko) | 자궁내막증 억제 방법 | |
KR950016738A (ko) | 알쯔하이머 질병의 억제 방법 | |
BR9408343A (pt) | Derivados 5-(2-imidazolinil amino) benzimidazol sua preparação e seu uso como agonistas alfa-2 adrenoceptor | |
KR950010888A (ko) | 평활근세포 증식 및 재발협착증을 억제하는 방법 | |
KR950016725A (ko) | 폐 고혈압성 질병을 억제하는 방법 | |
KR950010892A (ko) | 자궁 섬유증 억제 방법 | |
KR950016745A (ko) | 생리증상의 치료방법 및 이를 위한 조성물 | |
KR950010889A (ko) | 혈관형성 및 혈관형성성 질병을 억제하는 방법 | |
CA2371012A1 (en) | 4-(1h-pyrrol-1-yl) imidazoles | |
KR950010891A (ko) | 내성 종양을 치료하는 방법 | |
KR950016723A (ko) | 자가면역 질병의 억제 방법 | |
KR950016727A (ko) | 트롬보모듈린 발현을 증가시키는 방법 | |
ES2154669T3 (es) | Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para la inhibicion de la degradacion del cartilago. | |
KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
DK0474580T3 (da) | Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme | |
KR950016724A (ko) | 폐경기 후 여성의 리비도를 증가시키는 방법 | |
KR950016742A (ko) | 폐경후 여성의 씨엔에스 질환을 억제하는 방법 | |
RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
KR920011490A (ko) | 척추 손상으로 인한 반사이상항진 치료용 3-아릴-5-알킬티오-4h-1, 2, 4-트리아졸 | |
ES2093246T3 (es) | Compuestos de benzazepina terapeuticos. | |
KR880007494A (ko) | 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도 | |
KR910011807A (ko) | 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그 의 용도 | |
KR910018023A (ko) | 기억력 증진제로서 유용한 5-아릴-4-알킬-3h-1,2,4-트리아졸-3-티온 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030120 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |